Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic factors in bone sarcomas

G Saeter1, I Elomaa, Y Wahlqvist

  • 1Norwegian Radium Hospital, Oslo, Norway.

Acta Orthopaedica Scandinavica. Supplementum
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of carbon source and metal toxicity for potential acid mine drainage (AMD) treatment with an anaerobic sludge using sulfate-reduction.

Water science and technology : a journal of the International Association on Water Pollution Research·2021
Same author

Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project.

European journal of cancer care·2015
Same author

Moderate dose cranial radiotherapy causes central adrenal insufficiency in long-term survivors of childhood leukaemia.

Pituitary·2013
Same author

Proliferation of diploid hepatocytes and nonparenchymal (oval) cells during rat-liver regeneration in the presence of 2-acetylaminofluorene.

International journal of oncology·2011
Same author

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Returning to a changed ordinary life--families' lived experience after completing a child's cancer treatment.

European journal of cancer care·2010
Same journal

Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence.

Acta orthopaedica Scandinavica. Supplementum·2005
Same journal

Lumbar spinal fusion. Outcome in relation to surgical methods, choice of implant and postoperative rehabilitation.

Acta orthopaedica Scandinavica. Supplementum·2004
Same journal

The Scandinavian Sarcoma Group 25 years' experience.

Acta orthopaedica Scandinavica. Supplementum·2004
Same journal

Scientific publications from the Scandinavian Sarcoma Centers 1998-2003.

Acta orthopaedica Scandinavica. Supplementum·2004
Same journal

Meniscal tear--a feature of osteoarthritis.

Acta orthopaedica Scandinavica. Supplementum·2004
Same journal

Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.

Acta orthopaedica Scandinavica. Supplementum·2004
See all related articles

Prognostic factors for high-grade osteosarcoma and Ewing sarcoma are reviewed. Current methods lack consensus for risk stratification, highlighting the need for improved prognostication and targeted treatments for better patient outcomes.

Area of Science:

  • Pediatric Oncology
  • Skeletal Tumors
  • Cancer Prognostics

Background:

  • High-grade osteosarcoma and Ewing sarcoma are rare bone cancers affecting children and young adults.
  • Accurate prognostication is crucial for tailoring treatment intensity and improving patient outcomes.
  • Existing prognostic factors for these sarcomas have limitations, particularly in risk stratification for specific patient groups.

Purpose of the Study:

  • To review and synthesize current knowledge on prognostic factors in high-grade osteosarcoma and Ewing sarcoma.
  • To identify gaps in prognostic understanding and explore potential future advancements in detecting micrometastatic disease.

Main Methods:

  • Literature review of prognostic factors in high-grade osteosarcoma and Ewing sarcoma.
  • Analysis of existing data and clinical experience (SSG) to identify key prognostic indicators.

Related Experiment Videos

  • Discussion of emerging technologies for micrometastasis detection, such as immunoscintigraphy, immunohistochemistry, and PCR.

    • Main Results:

    • Key prognostic factors for osteosarcoma include metastases at diagnosis, tumor volume, age, sex, histologic response, and P-glycoprotein expression.
    • For adolescent, non-metastatic osteosarcoma, consensus on prognostic factors and risk stratification is lacking.
    • Prognostic factors for Ewing sarcoma include metastases at diagnosis, histologic response, tumor size, and pelvic localization; surgical treatment may reduce local recurrence.

    Conclusions:

    • There is a need for improved methods to stratify patients with osteosarcoma and Ewing sarcoma into risk groups for differentiated treatment.
    • Future advancements in detecting micrometastatic disease hold promise for more accurate prognostication.
    • Further research is needed to validate intensified treatment strategies and the role of high-dose therapy with stem cell rescue.